PeriCor Therapeutics Reports Positive Preclinical Results of GP531 at the European Heart Failure Congress in Nice
6/3/2009 8:37:18 AM
More...
|
PeriCor Therapeutics Appoints K. Tucker Andersen to Board of Directors
2/13/2008 7:12:11 AM
More...
|
PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation (SGP)
8/20/2007 11:40:08 AM
More...
|
PeriCor Therapeutics Appoints Larry G. Pickering To Board Of Directors
12/6/2006 10:18:55 AM
More...
|
PeriCor Therapeutics Mourns The Loss Of Ross Dixon, Ph.D., Vice President, Pharmaceutical Development
12/4/2006 2:22:38 PM
More...
|
PeriCor Therapeutics Elects Robert L. Engler, M.D. To Board Of Directors
7/6/2006 2:23:43 PM
More...
|
PeriCor Therapeutics Release: Acadesine Reduces Two-Year Mortality Following Heart Attacks In Heart Bypass Patients
5/12/2006 11:11:42 AM
More...
|
PeriCor Therapeutics Reports Positive Two-Year Mortality Results Of Acadesine At The American College of Cardiology's Scientific Session
3/14/2006 2:30:20 PM
More...
|